Reports: Thoreau Group in Advanced Talks to Acquire Ensemble Health Partners for $12 Billion

Thoreau Group, a private equity firm founded by former New Mountain Capital executive Matt Holt, is reportedly in advanced discussions to acquire Ensemble Health Partners in a deal valued at approximately $12 billion. Backed by Apollo Global Management, the acquisition would see Thoreau Group take a controlling stake in the medical billing and revenue cycle management (RCM) provider from current backers including Warburg Pincus and Berkshire Partners. This potential transaction highlights the intensifying interest of private equity firms in healthcare technology as providers increasingly turn to third-party automation to manage financial pressures.

The proposed $12 billion acquisition of Ensemble Health Partners marks a significant move for Matt Holt’s Thoreau Group, which is currently backed by Apollo Global Management. Ensemble, which manages more than $46 billion in net patient revenue, is currently supported by a consortium of investors including Warburg Pincus, Berkshire Partners, and Bon Secours Mercy Health. If finalized, the deal would establish Thoreau Group as the controlling stakeholder, providing Ensemble with the capital necessary to accelerate its development of an agentic AI platform designed to automate complex revenue cycle tasks.

This transaction represents a strategic pivot for Matt Holt, who previously orchestrated high-profile healthcare exits at New Mountain Capital, including the $8 billion sale of Signify Health to CVS Health and the $3.2 billion sale of Equian to Optum. While Holt’s earlier attempt to roll up five healthcare technology companies from New Mountain’s portfolio was canceled in March, the Ensemble deal offers a new launchpad for a potential roll-up strategy. By acquiring Ensemble, Thoreau Group could aggressively scale by folding other healthcare technology and RCM firms under a single umbrella to capture greater market share.

The deal arrives amid a surge of private equity interest in the revenue cycle management sector, driven by healthcare organizations' need to outsource billing services under the pressure of high medical expenses and thin margins. The market has seen significant consolidation recently, most notably the $8.9 billion acquisition of R1 RCM by TowerBrook Capital Partners and Clayton, Dubilier & Rice earlier in 2024. According to the Center for Economic and Policy Research, nearly 200 RCM companies were owned by private equity or venture capital firms as of mid-2024, highlighting the sector's status as a primary target for institutional investment and operational optimization.